According to Sunovion Pharmaceuticals, Zetonna ciclesonide nasal aerosol for the treatment of perennial and seasonal allergic rhinitis is now available throughout the US. The company announced in May that it would launch the product by this fall. Sunovion also markets Omnaris ciclesonide nasal spray for the treatment of allergic rhinitis and Alvesco ciclesonide … [Read more...] about Sunovion launches Zetonna nasal aerosol in US
Business
Quintiles to promote Almirall respiratory products in UK, beginning with Eklira Genuair
Quintiles will promote respiratory drugs from Almirall in the UK, starting with the newly approved Eklira Genuair aclidinium bromide dry powder inhaler for the treatment of COPD. Quintiles performed some of the clinical study work for the product. Menarini will market the DPI in most of Europe as Bretaris Genuair. Almirall UK General Manager Carlos Gallardo … [Read more...] about Quintiles to promote Almirall respiratory products in UK, beginning with Eklira Genuair
Unigene responds to EMA recommendation against use of calcitonin nasal spray
Unigene Laboratories, which manufactures Fortical calcitonin nasal spray for the treatment of osteoporosis, has requested product safety data submitted to the EMA's Committee for Medicinal Products for Human Use (CHMP) in response to the EMA's recommendation against use of calcitonin nasal sprays. The EMA report, issued on July 19, 2012, notes a 2.4% increase in the … [Read more...] about Unigene responds to EMA recommendation against use of calcitonin nasal spray
“Asthma Inhalers Relief Act of 2012” aims to allow sales of remaining CFC inhalers
The US House of Representatives held a meeting on July 18, 2012 regarding the "Asthma Inhalers Relief Act of 2012," which is intended "To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers." Witnesses who … [Read more...] about “Asthma Inhalers Relief Act of 2012” aims to allow sales of remaining CFC inhalers
Alexza gets $20 million in new funding
Alexza Pharmaceuticals has announced that it has issued 80,429 shares of common stock to Azimuth Opportunity as the two companies have reached an agreement for a committed equity financing facility under which Alexza has the option to sell Azimuth up to $20 million of its registered common stock over 2 years. The two companies entered a similar agreement in May 2010 … [Read more...] about Alexza gets $20 million in new funding
UK supermarket chain to begin selling inhalers over the counter
Supermarket chain Asda says that it will become the first retailer in the UK to sell asthma reliever inhalers over the counter when its pharmacies begin offering salbutamol (albuterol) inhalers for sale on July 24. Asda has pharmacies in 218 stores. Patients over the age of 16 will be able to purchase two inhalers for £7 after filling out a simple questionnaire. … [Read more...] about UK supermarket chain to begin selling inhalers over the counter
Private investment firm to acquire Par Pharmaceutical
Par Pharmaceutical's board of directors has voted unanimously in favor of acquisition by private investment firm TPG for $1.9 billion, with Par shareholders getting $50 cash per share of Par common stock. Par and its subsidiary Strativa market several OINDPs, including Nascobal cyanocobalamin nasal spray and Miacalcin calcitonin nasal spray. Par Chairman and CEO … [Read more...] about Private investment firm to acquire Par Pharmaceutical
Gerresheimer adds inhaler manufacturing capability in the Czech Republic
Gerresheimer is adding 3,500 square meters to its medical plastics facility in Horsovsky Tyn, Czech Republic, at a cost of about €18 million, adding to a previously announced expansion at the site. According to the company, it will hire approximately 200 more personnel over the next two years to handle increased production of inhalers and other devices at the site. … [Read more...] about Gerresheimer adds inhaler manufacturing capability in the Czech Republic
Hi-Tech Pharmacal attributes sales increase to nasal sprays
Hi-Tech Pharmacal has reported a 10% increase in net sales of generic products for the quarter ended April 30, 2012 compared to the same quarter in 2011, an increase due primarily to a sales increase for fluticasone proprionate nasal spray. According to the company, sales of fluticasone propionate nasal spray were up from $26.9 million in the same period last year to … [Read more...] about Hi-Tech Pharmacal attributes sales increase to nasal sprays
DPT Labs acquired by Renaissance
Renaissance Acquisition Holdings has acquired Texas-based CDMO DPT Laboratories, which offers MDI and nasal spray testing and manufacturing. DPT has facilities in San Antonio, TX and Lakewood, NJ. According to the company, the management team and business will continue as before. DPT President and COO Paul Johnson commented, “Renaissance and its management team … [Read more...] about DPT Labs acquired by Renaissance